Business
Share Awards to Executive Directors
On August 28, 2025, Eco Animal Health Group PLC granted nominal cost conditional share options to Executive Directors under the Long Term Incentive Plan (LTIP) covering 374,318 ordinary shares, representing approximately 0.55% of the company's issued share capital. The CEO, David Hallas, received 215,106 share awards, while the CFO, Chris Wilks, received 159,212. Additionally, under the Deferred Bonus Plan (DBS), Hallas received options over 35,472 ordinary shares and Wilks received options over 24,823 ordinary shares, representing approximately 0.09% of the company's issued share capital. These DBS awards relate to the deferral of 33% of the annual bonus for Executive Directors earned for the financial year ended March 31, 2025. The share options are priced at 5p each. Disclaimer*
About this update from Eco Animal Health Group Plc
[{"type":"text","content":"\n\n29 August 2025\n \n \n \n\nECO Animal Health Group plc\n(\"ECO\" or the \"Company\")\n \nShare Awards to Executive Directors\n ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announce that on 28 August 2025, nominal cost conditional share options were granted under the Company's Long Term Incentive Plan (\"LTIP\") over 374,318 ordinary shares in the Company (representing approximately 0.55 percent of the Company's issued share capital) to the Executive Directors listed below.\n \n\n\n\n\nName\n\n\nPosition\n\n\nNumber of Share Awards\n\n\n\n\nDavid Hallas\n\n\nChief Executive Officer\n\n\n215,106\n\n\n\n\nChris Wilks\n\n\nChief Financial Officer\n\n\n159,212\n\n\n\n\n \nThese awards under the LTIP are subject to performance conditions being met which have been set by the Company's Remuneration Committee and relate to Total Shareholder Return (\"TSR\") and Research and Development (\"R&D\") targets. Subject to the performance conditions being met, awards will vest after the end of a three-year vesting period. Further details on the LTIP can be found in the Company's 2025 Annual Report which was published on 28 August 2025.\nIn addition, on 28 August 2025 nominal cost share options were granted under the Company's Deferred Bonus Plan (\"DBS\") over 60,295 ordinary shares in the Company (representing approximately 0.09 percent of the Company's issued share capital) to the two Executive Directors listed below. These awards relate to the deferral of 33% of the annual bonus for Executive Directors earned in respect of the Company's financial year ended 31 March 2025.\n \n\n\n\n\nName\n\n\nPosition\n\n\nNumber of Deferred Share Options\n\n\n\n\nDavid Hallas\n\n\nChief Executive Officer\n\n\n35,472\n\n\n\n\nChris Wilks\n\n\nChief Financial Officer\n\n\n24,823\n\n\n\n\n \nAs indicated in the Circular to shareholders dated 4 February 2021, the DBS has been established to allow the Remuneration Committee to require a significant part of the annual bonuses paid to Executive Directors to be deferred in exchange for an award of nominal cost options which vest after 3 years and are subject to malice and clawback provisions.\n \n-Ends-\nFor further informa...